ECB should have made county talent pathway free, says Cindy Butts
Tyson Fury reveals his wife suffered a miscarriage on eve of Usyk fight
Project to build German EV microchip factory put on hold
Resistance to daptomycin in near-untreatable superbug caused by a different antibiotic, study finds
No surgical abortion providers in seven out of 10 Victorian local government areas, report finds
Nice approves rimegepant for preventing migraines in cases where at least three previous treatments have failed
Thousands of people in England who get migraines could benefit from a drug that has been approved on the NHS.
The National Institute for Health and Care Excellence (Nice), the drugs regulator, said it was recommending rimegepant for preventing migraines in the approximately 145,000 adults where at least three previous preventive treatments had failed.
More Stories
Sweden warns of heightened risk of Russian sabotage
Human brain can process certain sentences in ‘blink of an eye’, says study
Long-extinct animals could be resurrected as robots to shed light on evolution